149 related articles for article (PubMed ID: 28284262)
21. Persistent Empiric COPD Diagnosis and Treatment After Pulmonary Function Test Showed No Obstruction.
Fortis S; Corazalla EO; Jacobs DR; Kim HJ
Respir Care; 2016 Sep; 61(9):1192-200. PubMed ID: 27165420
[TBL] [Abstract][Full Text] [Related]
22. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
[TBL] [Abstract][Full Text] [Related]
23. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
[TBL] [Abstract][Full Text] [Related]
24. Over diagnosis of chronic obstructive pulmonary disease in an underserved patient population.
Ghattas C; Dai A; Gemmel DJ; Awad MH
Int J Chron Obstruct Pulmon Dis; 2013; 8():545-9. PubMed ID: 24348030
[TBL] [Abstract][Full Text] [Related]
25. Combining case-finding methods for COPD in primary care: a large, two-stage design study.
Soriano JB; Molina J; Miravitlles M
Int J Tuberc Lung Dis; 2018 Jan; 22(1):106-111. PubMed ID: 29297434
[TBL] [Abstract][Full Text] [Related]
26. Identifying possible asthma-COPD overlap syndrome in patients with a new diagnosis of COPD in primary care.
Baarnes CB; Kjeldgaard P; Nielsen M; Miravitlles M; Ulrik CS
NPJ Prim Care Respir Med; 2017 Jan; 27():16084. PubMed ID: 28055002
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain).
Román-Rodríguez M; van Boven JF; Vargas F; Contreras CC; Lamelas G; Gestoso S; Góngora M; Corredor M; Esteva M
Eur J Gen Pract; 2016 Dec; 22(4):232-239. PubMed ID: 27597172
[TBL] [Abstract][Full Text] [Related]
28. The objective evaluation of obstructive pulmonary diseases with spirometry.
Ozkaya S; Dirican A; Tuna T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
[TBL] [Abstract][Full Text] [Related]
29. Paid employment in subjects with and without chronic obstructive pulmonary disease in five Latin American cities: the PLATINO study.
Montes de Oca M; Halbert RJ; Talamo C; Perez-Padilla R; Lopez MV; Muiño A; Jardim JR; Valdivia G; Pertuzé J; Moreno D; Menezes AM;
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1259-64, i-iii. PubMed ID: 21943855
[TBL] [Abstract][Full Text] [Related]
30. Optimizing chronic obstructive pulmonary disease management in primary care.
Yawn BP
South Med J; 2011 Feb; 104(2):121-7. PubMed ID: 21079536
[TBL] [Abstract][Full Text] [Related]
31. Predictors of COPD in symptomatic smokers and ex-smokers seen in primary care.
Tupper OD; Kjeldgaard P; Løkke A; Ulrik CS
Chron Respir Dis; 2018 Nov; 15(4):393-399. PubMed ID: 29486583
[TBL] [Abstract][Full Text] [Related]
32. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study.
Al Ghobain M; Alhamad EH; Alorainy HS; Al Kassimi F; Lababidi H; Al-Hajjaj MS
Int J Tuberc Lung Dis; 2015 Oct; 19(10):1252-7. PubMed ID: 26459542
[TBL] [Abstract][Full Text] [Related]
33. Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD.
Manoharan A; Morrison AE; Lipworth BJ
Lung; 2016 Apr; 194(2):259-66. PubMed ID: 26758884
[TBL] [Abstract][Full Text] [Related]
34. The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes.
Anzueto A; Wise R; Calverley P; Dusser D; Tang W; Metzdorf N; Dahl R
Respir Res; 2015 Sep; 16(1):107. PubMed ID: 26369563
[TBL] [Abstract][Full Text] [Related]
35. Difficulties in differential diagnosis of COPD and asthma in primary care.
Miravitlles M; Andreu I; Romero Y; Sitjar S; Altés A; Anton E
Br J Gen Pract; 2012 Feb; 62(595):e68-75. PubMed ID: 22520766
[TBL] [Abstract][Full Text] [Related]
36. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
Bölükbas S; Eberlein M; Eckhoff J; Schirren J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
38. Expiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admission.
Jetmalani K; Timmins S; Brown NJ; Diba C; Berend N; Salome CM; Wen FQ; Chen P; King GG; Farah CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():939-45. PubMed ID: 25999709
[TBL] [Abstract][Full Text] [Related]
39. Impact of bronchodilator use on the prevalence of COPD in population-based samples.
Pérez-Padilla R; Hallal PC; Vázquez-García JC; Muiño A; Máquez M; López MV; de Oca MM; Tálamo C; Valdivia G; Pertuzé J; Jardim J; Menezes AM;
COPD; 2007 Jun; 4(2):113-20. PubMed ID: 17530504
[TBL] [Abstract][Full Text] [Related]
40. Tiotropium in COPD patients not previously receiving maintenance respiratory medications.
Adams SG; Anzueto A; Briggs DD; Menjoge SS; Kesten S
Respir Med; 2006 Sep; 100(9):1495-503. PubMed ID: 16698259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
